Chronic intermittent alcohol disrupts the GluN2B-associated proteome and specifically regulates group I mGlu receptor-dependent long-term depression

Addict Biol. 2017 Mar;22(2):275-290. doi: 10.1111/adb.12319. Epub 2015 Nov 8.

Abstract

N-Methyl-d-aspartate receptors (NMDARs) are major targets of both acute and chronic alcohol, as well as regulators of plasticity in a number of brain regions. Aberrant plasticity may contribute to the treatment resistance and high relapse rates observed in alcoholics. Recent work suggests that chronic alcohol treatment preferentially modulates both the expression and subcellular localization of NMDARs containing the GluN2B subunit. Signaling through synaptic and extrasynaptic GluN2B-NMDARs has already been implicated in the pathophysiology of various other neurological disorders. NMDARs interact with a large number of proteins at the glutamate synapse, and a better understanding of how alcohol modulates this proteome is needed. We employed a discovery-based proteomic approach in subcellular fractions of hippocampal tissue from chronic intermittent alcohol (CIE)-exposed C57Bl/6J mice to gain insight into alcohol-induced changes in GluN2B signaling complexes. Protein enrichment analyses revealed changes in the association of post-synaptic proteins, including scaffolding, glutamate receptor and PDZ-domain binding proteins with GluN2B. In particular, GluN2B interaction with metabotropic glutamate (mGlu)1/5 receptor-dependent long-term depression (LTD)-associated proteins such as Arc and Homer 1 was increased, while GluA2 was decreased. Accordingly, we found a lack of mGlu1/5 -induced LTD while α1 -adrenergic receptor-induced LTD remained intact in hippocampal CA1 following CIE. These data suggest that CIE specifically disrupts mGlu1/5 -LTD, representing a possible connection between NMDAR and mGlu receptor signaling. These studies not only demonstrate a new way in which alcohol can modulate plasticity in the hippocampus but also emphasize the utility of this discovery-based proteomic approach to generate new hypotheses regarding alcohol-related mechanisms.

Keywords: Alcohol addiction; NMDA receptor; proteomics; synaptic plasticity.

MeSH terms

  • Animals
  • Central Nervous System Depressants / administration & dosage
  • Central Nervous System Depressants / pharmacology*
  • Cytoskeletal Proteins / drug effects
  • Cytoskeletal Proteins / metabolism
  • Ethanol / administration & dosage
  • Ethanol / pharmacology*
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Homer Scaffolding Proteins / drug effects
  • Homer Scaffolding Proteins / metabolism
  • Long-Term Synaptic Depression / drug effects*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / metabolism
  • Proteome / drug effects
  • Proteome / metabolism
  • Receptors, Metabotropic Glutamate / drug effects*
  • Receptors, Metabotropic Glutamate / metabolism
  • Receptors, N-Methyl-D-Aspartate / drug effects*
  • Receptors, N-Methyl-D-Aspartate / genetics
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Signal Transduction

Substances

  • Central Nervous System Depressants
  • Cytoskeletal Proteins
  • Homer Scaffolding Proteins
  • NR2B NMDA receptor
  • Nerve Tissue Proteins
  • Proteome
  • Receptors, Metabotropic Glutamate
  • Receptors, N-Methyl-D-Aspartate
  • activity regulated cytoskeletal-associated protein
  • Ethanol